Location: Heidelberg
Synced from ClinicalTrials.gov · August 07, 2026
Clinical studies recruiting near Heidelberg
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
Observational Study Protocol: LIVER-R Phase N/A · Research Site · AstraZeneca · NCT06252753 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract Phase 3 · Austin Health · Eli Lilly and Company · NCT07218380 Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2 Phase 3 · University Hospital Heidelberg · Joseph Broderick, MD · NCT07227246 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W Phase 3 · Heidelberg University Hospital · Pfizer · NCT07028853 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia Phase 3 · Universitätsklinikum Heidelberg AöR · Princess Maxima Center for Pediatric Oncology · NCT05327894 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Phase 2/Phase 3 · Austin Health · Bristol-Myers Squibb · NCT07106762 Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study NA · Austin Health · University of Melbourne · NCT07055542 Evaluation of Optical Coherence Tomography in Dentistry NA · Department of Orthodontics and Dentofacial Orthopaedics, Uni · University of Heidelberg Medical Center · NCT03753256 Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients Phase 2 · Universitaetsklinikum Heidelberg · Miltenyi Biomedicine GmbH · NCT04844866 Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma Wi Phase 3 · Research Site · AstraZeneca · NCT07509151 Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer Phase 3 · Universitätsklnikum Heidelberg · AGO Study Group · NCT05009082 PulseSelect™ PFA Global Registry Phase N/A · Universitätsklinikum Heidelberg · Medtronic Cardiac Ablation Solutions · NCT06393920 A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have P Phase 2 · Thoraxklinik-Heidelberg gGmbH · Pfizer · NCT07073820 An Open Label Dose Finding Study of PTT-4256 in Patients With Solid Tumours (RAISIC-1). Phase 1/Phase 2 · Austin Health · Pathios Therapeutics Pty Ltd · NCT06634849 A Non-interventional, Prospective Study With Benralizumab Phase N/A · Research Site · AstraZeneca · NCT06422078 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop Phase 3 · Austin Health · Hoffmann-La Roche · NCT06793215 Natural History Study of Patients With Succinic Semialdehyde Dehydrogenase (SSADH) Deficiency Phase N/A · University Children's Hospital · Boston Children's Hospital · NCT03758521 Perturbation-Based Treadmill Training to Prevent Unrecovered Falls in Geriatric Patients NA · Geriatric Center, Heidelberg University Hospital, Agaplesion · University of Oldenburg · NCT06652828 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov Phase 3 · Austin Health, Heidelberg Repatriation Hospital · Amgen · NCT07037433 The Myeloid Neoplasms Biology and Outcome Project Phase N/A · UHHeidelberg · University Hospital Heidelberg · NCT05074316 A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advance Phase 1/Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT06885034 Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension Phase 2/Phase 3 · Austin Hospital · Monash University · NCT05678621 Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib + Phase N/A · Research Site · AstraZeneca · NCT06380738 DV 100 as a Framework for the Hospital Incident Command System Phase N/A · University Hospital Heidelberg · University Hospital Heidelberg · NCT06913010 Intelligent Vacuum Assisted Biopsy Immediately Before Surgery As an Intra- or Pre-Operative Surrogate for Patient Respon NA · Brustzentrum Heidelberg · Klinik Hirslanden, Zurich · NCT04289935 PANHPVAX, Study of a New HPV Vaccine in Healthy Volunteers EARLY_Phase 1 · University Hospital Department of Clinical Pharmacology and · German Cancer Research Center · NCT05208710 Longitudinal Observational Study on the Course of Cystic Fibrosis Lung Disease in Patients Following Newborn Screening Phase N/A · University Children's Hospital Heidelberg, Cystic Fibrosis C · Heidelberg University · NCT02270476 A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Phase N/A · HPK Heidelberger Praxisklinik · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615 Magnetic Resonance-guided Adaptive Stereotactic Body Radiotherapy for Hepatic Metastases Phase 2 · University Hospital of Heidelberg, Radiation Oncology · University Hospital Heidelberg · NCT05027711 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS Phase 3 · Austin Health · Eli Lilly and Company · NCT06890598
Look up another city
Look up another condition